[1] 徐海萍, 高继勇, 宋凤娟, 等.  骨髓纤维化74例临床分析[J]. 白血病·淋巴瘤, 2006, 15(5): 369-371.   doi: 10.3760/cma.j.issn.1009-9921.2006.05.018
Xu HP, Gao JY, Song FJ, et al.  Clinical analysis of 74 cases of myelofibrosis[J]. J Leuk Lymphoma, 2006, 15(5): 369-371.   doi: 10.3760/cma.j.issn.1009-9921.2006.05.018
[2] Balkan C, Ersoy B, Nese N.  Myelofibrosis associated with severe vitamin D deficiency rickets[J]. J Int Med Res, 2005, 33(3): 356-359.   doi: 10.1177/147323000503300311
[3] Butt YM, Chen WN.  Myelofibrosis secondary to renal osteodystrophy[J]. Blood, 2016, 128(16): 2104-.   doi: 10.1182/blood-2016-07-726182
[4] Lim DJ, Oh EJ, Park CW, et al.  Pancytopenia and secondary myelofibrosis could be induced by primary hyperparathyroidism[J]. Int J Lab Hematol, 2007, 29(6): 464-468.   doi: 10.1111/j.1365-2257.2006.00877.x
[5] Del Porto F, Tatarelli C, Di Napoli A, et al.  Systemic lupus erythematosus and myelofibrosis: a case report and revision of literature[J]. Leuk Res Rep, 2018, 9: 58-64.   doi: 10.1016/j.lrr.2018.04.004
[6] Valent P, Horny HP, Escribano L, et al.  Diagnostic criteria and classification of mastocytosis: a consensus proposal[J]. Leuk Res, 2001, 25(7): 603-625.   doi: 10.1016/S0145-2126(01)00038-8
[7] Ozdemir D, Dagdelen S, Erbas T.  Systemic mastocytosis[J]. Am J Med Sci, 2011, 342(5): 409-415.   doi: 10.1097/MAJ.0b013e3182121131
[8] Fritz J, Fishman EK, Carrino JA, et al.  Advanced imaging of skeletal manifestations of systemic mastocytosis[J]. Skeletal Radiol, 2012, 41(8): 887-897.   doi: 10.1007/s00256-012-1374-9
[9] Djelbani-Ahmed S, Chandesris MO, Mekinian A, et al.  FDG-PET/CT findings in systemic mastocytosis: a French multicentre study[J]. Eur J Nucl Med Mol Imaging, 2015, 42(13): 2013-2020.   doi: 10.1007/s00259-015-3117-3